Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.
2.

Use of proxies to measure health and functional status in epidemiologic studies of community-dwelling women aged 65 years and older.

Magaziner J, Bassett SS, Hebel JR, Gruber-Baldini A.

Am J Epidemiol. 1996 Feb 1;143(3):283-92.

PMID:
8561163
3.

Determining the incidence of different subtypes of stroke: results from the Perth Community Stroke Study, 1989-1990.

Anderson CS, Jamrozik KD, Burvill PW, Chakera TM, Johnson GA, Stewart-Wynne EG.

Med J Aust. 1993 Jan 18;158(2):85-9.

PMID:
8419781
5.

The role of lifestyle factors in the etiology of stroke. A population-based case-control study in Perth, Western Australia.

Jamrozik K, Broadhurst RJ, Anderson CS, Stewart-Wynne EG.

Stroke. 1994 Jan;25(1):51-9.

PMID:
8266383
6.

Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects.

Patrono C, Ciabattoni G, Pinca E, Pugliese F, Castrucci G, De Salvo A, Satta MA, Peskar BA.

Thromb Res. 1980 Feb 1-15;17(3-4):317-27. No abstract available.

PMID:
7368167
7.

"AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia.

Bousser MG, Eschwege E, Haguenau M, Lefaucconnier JM, Thibult N, Touboul D, Touboul PJ.

Stroke. 1983 Jan-Feb;14(1):5-14.

8.

Acetylsalicylic acid in the prevention of stroke in patients with reversible cerebral ischemic attacks. A Danish cooperative study.

Sorensen PS, Pedersen H, Marquardsen J, Petersson H, Heltberg A, Simonsen N, Munck O, Andersen LA.

Stroke. 1983 Jan-Feb;14(1):15-22.

9.

[Controlled cooperative trial of secondary prevention of cerebral ischemic accidents caused by atherosclerosis, using aspirin and dipyridamole].

Bousser MG, Eschwège E, Haguenau M, Lefauconnier JM, Thibult N, Touboul D, Touboul PJ.

Presse Med. 1983 Dec 29;12(48):3049-57. French.

PMID:
6228913
10.

Risk factors for spontaneous cerebral hematomas. Case-control study.

Calandre L, Arnal C, Ortega JF, Bermejo F, Felgeroso B, del Ser T, Vallejo A.

Stroke. 1986 Nov-Dec;17(6):1126-8.

11.
12.

Controlled trial of aspirin in cerebral ischemia: an addendum.

Lemak NA, Fields WS, Gary HE Jr.

Neurology. 1986 May;36(5):705-10.

PMID:
3517694
13.

Randomised trial of prophylactic daily aspirin in British male doctors.

Peto R, Gray R, Collins R, Wheatley K, Hennekens C, Jamrozik K, Warlow C, Hafner B, Thompson E, Norton S, et al.

Br Med J (Clin Res Ed). 1988 Jan 30;296(6618):313-6.

14.

Danish very-low-dose aspirin after carotid endarterectomy trial.

Boysen G, Sørensen PS, Juhler M, Andersen AR, Boas J, Olsen JS, Joensen P.

Stroke. 1988 Oct;19(10):1211-5.

15.
16.
17.

Final report on the aspirin component of the ongoing Physicians' Health Study.

Steering Committee of the Physicians' Health Study Research Group.

N Engl J Med. 1989 Jul 20;321(3):129-35.

18.

Pharmacology of platelet inhibitors.

Harker LA, Fuster V.

J Am Coll Cardiol. 1986 Dec;8(6 Suppl B):21B-32B. Review.

PMID:
2431020
20.

European Stroke Prevention Study. ESPS Group.

[No authors listed]

Stroke. 1990 Aug;21(8):1122-30.

Supplemental Content

Support Center